Actively Recruiting

Age: 22Years +
All Genders
Healthy Volunteers
NCT07149740

Data Gathering for A10900

Led by Optos, PLC · Updated on 2026-02-13

180

Participants Needed

4

Research Sites

44 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The objective of this study is to gather Optical Coherence Tomography (OCT) data on normal and diseased eyes

CONDITIONS

Official Title

Data Gathering for A10900

Who Can Participate

Age: 22Years +
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Participants must be 22 years of age or older on the date of informed consent
  • Participants must be able to understand and willing to sign the informed consent
  • For retinal disease group: BCVA 20/400 or better in study eye, diagnosed retinal pathology including macular degeneration, diabetic retinopathy, macular hole, epiretinal membrane, central serous retinopathy, or others
  • For glaucoma group: BCVA 20/40 or better in study eye, history of visual field defects consistent with glaucomatous optic nerve damage, glaucomatous optic nerve damage with structural abnormalities
  • For corneal disease group: presenting with corneal disease such as contact lens disorders, post-refractive surgery, dry eye, keratoconus
  • For normal group: normal eyes with BCVA 20/40 or better, including cataracts, LASIK, PRK, and peripheral pathology not affecting the posterior pole
  • Participants must be able to comply with study procedures
Not Eligible

You will not qualify if you...

  • Unable to tolerate ophthalmic imaging
  • Unable to obtain acceptable OCT images due to ocular media opacity or other reasons
  • Condition or situation posing significant risk, confounding study results, or interfering with participation
  • For retinal group: presence of glaucoma or other ocular pathology in study eye
  • For glaucoma group: no reliable visual field test within the past year, or any ocular pathology other than glaucoma
  • For corneal group: ocular media not clear enough for acceptable OCT images
  • For normal group: history of leukemia, dementia, or multiple sclerosis

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 4 locations

1

Ketchum Health

Anaheim, California, United States, 92807

Actively Recruiting

2

Eye Disease Consultants, LLC

West Hartford, Connecticut, United States, 06107

Actively Recruiting

3

Eye Care and Laser Surgery of Newton Wellselley

Wellesley Hills, Massachusetts, United States, 02481

Completed

4

Charles Retina Institute

Germantown, Tennessee, United States, 38138

Actively Recruiting

Loading map...

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

4

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here